HOW WE CAN DIAGNOSE THE FIRMS' DISEASES USING GREY SYSTEMS THEORY

被引:0
|
作者
Maracine, Virginia [1 ]
Delcea, Camelia [1 ]
机构
[1] Bucharest Acad Econ Studies, Dept Econ Cybernet, Bucharest, Romania
关键词
Grey systems theory; Firm's diseases; GM models; Incidence matrix; Firm's diagnosis; Symptoms matrix; DISCRIMINANT-ANALYSIS; FINANCIAL RATIOS; PREDICTION; FAILURE; BANKRUPTCY;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
The core of our paperwork consists in determine a "matrix of symptoms", based on grey systems theory. The symptoms of a firm can be represented by economic-financial ratios, usually used by analysts to make predictions and give recommendations. The ability to create such a matrix of symptoms implies that given level of symptom's intensity we can determinate if the analyzed firm presents some "diseases". In this article, by diseases we understand the causes which generate anomalies in the company's activity. By using such a matrix of symptoms, the activity of the analyst can be really improved, the quality of his or her recommendations rising significantly. First part of our article describes the evolutions of the methods used for diagnosing the companies' diseases. The second part focuses on the methods of diagnosis belonging to the Grey Systems Theory, while the third one illustrates their applications infirm's activity analysis, including also a numerical example. We conclude our paper with some remarks over the role and the utility of the grey systems theory in diagnosing the firms' diseases.
引用
收藏
页码:39 / 55
页数:17
相关论文
共 50 条
  • [31] How can we diagnose pure opium overdose cases in retrospective medical chart reviews?
    Sanaei-Zadeh, Hossein
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (05): : 880 - 881
  • [32] Heart Transplantation in Systemic Diseases: How Far Can We Go?
    Di Nora, C.
    Sponga, S.
    Nalli, C.
    Benedetti, G.
    Ferrara, V.
    Lechiancole, A.
    Vendramin, I.
    Livi, U.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S207 - S207
  • [33] How can we improve the care of patients with benign anorectal diseases?
    Correa, Jessica
    Luis Lopez-Negre, Jose
    Barrio, Carmen
    Pares, David
    ATENCION PRIMARIA, 2014, 46 (10): : 582 - 583
  • [34] How can we target oxidative stress in the treatment of neurodegenerative diseases?
    Akasaka, Hironari
    Ruan, Ke-He
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (08) : 835 - 839
  • [35] Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas, George D.
    Dimiroulas, Theodoros
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (04) : 473 - 476
  • [36] United we stand, divided we fall: How firms can engage consumers in their fight against counterfeits
    Cesareo, Ludovica
    Stoettinger, Barbara
    BUSINESS HORIZONS, 2015, 58 (05) : 527 - 537
  • [37] Chronic diseases 1 - Preventing chronic diseases: how many lives can we save?
    Strong, K
    Mathers, C
    Leeder, S
    Beaglehole, R
    LANCET, 2005, 366 (9496): : 1578 - 1582
  • [38] How can we design better networks for DSM systems?
    Dai, DL
    Panda, DK
    PARALLEL COMPUTER ROUTING AND COMMUNICATION, 1998, 1417 : 171 - 184
  • [39] Chasms in agrifood systems:: rethinking how we can contribute
    Friedland, William H.
    AGRICULTURE AND HUMAN VALUES, 2008, 25 (02) : 197 - 201
  • [40] “Chasms” in agrifood systems: rethinking how we can contribute
    William H. Friedland
    Agriculture and Human Values, 2008, 25 : 197 - 201